Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Cancer Chemotherapy and Pharmacology

Issue Special Issue 1/2004

Content (15 Articles)

Preface

Hidehiko Saito

Clinical overview: adjuvant therapy of gastrointestinal cancer

John S. Macdonald

Development of gastric cancer associated with Helicobacter pylori infection

Toshiro Sugiyama

Analysis of gastric cancer with cDNA microarray

Naotsugu Haraguchi, Hiroshi Inoue, Koshi Mimori, Fumiaki Tanaka, Tohru Utsunomiya, Kouji Yoshikawa, Masaki Mori

Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives

Junichi Sakamoto, Satoshi Morita, Yasuhiro Kodera, Mahbubur Rahman, Akimasa Nakao

Integration of novel agents in the treatment of colorectal cancer

Syma Iqbal, Heinz-Josef Lenz

Chemoprevention of colorectal cancer

Yoshiro Niitsu, Tetsuji Takayama, Koji Miyanishi, Atsushi Nobuoka, Tsuyoshi Hayashi, Takehiro Kukitsu, Kunihiro Takanashi, Hirotoshi Ishiwatari, Tomoyuki Abe, Takahiro Kogawa, Minoru Takahashi, Takuya Matsunaga, Junji Kato

Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors—a review

Akira Sawaki, Kenji Yamao

Prevention of colorectal cancer through the use of COX-2 selective inhibitors

Richard M. Peek Jr

Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer

Richard M. Goldberg, Sharlene Gill

CIN-ful cancers

Harith Rajagopalan, Christoph Lengauer

Molecular targeting therapy for pancreatic cancer

Henry Q. Xiong

New approaches for pancreatic cancer in Japan

Takuji Okusaka, Yasuhiro Matsumura, Kazunori Aoki

Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan

Masashi Mizokami, Yasuhito Tanaka

Key research issues in the management of hepatocellular carcinoma

Alan P. Venook

Sep 04
Issue: 3/2004
Oct 04
Issue: 4/2004

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits